In the course of DKD progression, key inflammatory mediators—such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)—are significantly upregulated [40,41]. This evidence concerns the gene IL6 and diabetic kidney disease.